Wurth Douglas Clark 4

What Happened Douglas Clark Wurth, a director of Bluejay Diagnostics, purchased 12,500 shares of the company's common stock in a private placement on March 14, 2026. The shares were acquired at $2.00 per share for a total cash outlay of $25,000. This was a purchase (insider buying), which investors often consider more informative than routine sales.

Key Details

• Transaction date: March 14, 2026 — Purchase (code P).
• Price and amount: 12,500 shares at $2.00 per share; total value $25,000.
• Filing date: May 18, 2026 (filed ~65 days after the transaction) — late filing.
• Shares owned after transaction: Not specified in the Form 4 provided.
• Footnotes: (F1) Shares were bought directly from the issuer in a private placement. (F2) 34 of the shares are held by Wurth Holdings LLC, an entity controlled by Mr. Wurth.

Context Because this was a private placement from the issuer, the transaction involved newly issued shares rather than an open-market purchase, which can have different implications (including modest dilution). The purchase size ($25k) is relatively small for an insider buy and should be weighed accordingly. The late filing delays public disclosure of the trade and reduces immediacy for investors tracking insider activity.